<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180527039868N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-07-04</date_registration>
      <primary_sponsor>Sultan Qaboos University</primary_sponsor>
      <public_title>Kegel exercise and stress urinary incontinence</public_title>
      <acronym></acronym>
      <scientific_title>The effect of home based Kegel exercise on decreasing severity of symptoms and improving quality of life in Omani females identified to have Stress Urinary Incontinence: A prospective randomized controlled study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2639-10-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/31596</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The study involves three primary healthcare centers (PHC) in the same area with nearly similar sociodemographic profile of the attendees who avail PHC services. Hence for the purpose of this study and analysis, the three PHCs will be treated as one unit. From among the participants identified having Stress Urinary Incontinence from our ongoing phase I study titled "Prevalence, risk factors, impact on quality of life of Urinary incontinence in urban Omani women", the PI and Co-PI will contact all identified eligible females on telephone; explain the importance of the phase II RCT and invite her to participate in the phase II RCT after explaining the protocol in brief over phone.
The subjects willing to be a part of phase II study will be requested to report on a pre-specified day to the same PHC where they were enrolled, explained the protocol of the trial individually by the PI/Co-PI and informed consent taken. The consenting subjects will be assigned identification numbers. A computer based simple random sequence generator will then be used separately at each PHC to direct the subject either to the intervention or control group. The random allocation process will continue till the required sample size target is achieved. Allocation concealment is not possible due to the nature of our study. Adequate care will be taken to prevent contamination. 
Two days will be allocated to each of the PHC for conduct of the trial. The whole research team consisting of PI, Co-PI and physiotherapist will be available at each center of study on the specified days, Blinding description: The research physiotherapist , is the investigator and outcome assessor also, will be assessing all the subjects at baseline and also 12 weeks post-intervention will be blinded to the groups to which the subject belongs.</study_design>
      <phase>3</phase>
      <hc_freetext>Stress urinary incontinence.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients in the intervention group will report to the Co-PI who is family physician having undergone special training in Kegel Exercise. She will educate the participants individually using audio-visual aids about the anatomy of pelvic floor muscles, continence mechanism and the importance of Kegel’s exercise in management of UI problems and advice the subjects about daily schedule of performing the Kegel’s exercises. The instructions for Kegel exercise involves endurance and speed training. Endurance training (tonic contractions) of pelvic floor muscles consists of  slow velocity close to maximum contractions for 3-10 seconds (according to the initial pelvic floor assessment) followed by relaxation for similar duration.  For example, if the initial pelvic floor assessment shows a time of sustained contraction of 5 seconds, the woman will be instructed to have slow contractions for 5 seconds for the first week, then increase it to 6 seconds in the next week and so on with the aim of reaching 10 seconds. Thus, the time of sustained contraction will be increased by 1 second per week up to 10 seconds. Speed training (phasic contractions) involves fast moderately strong contractions for 2 seconds followed by relaxation for 2 seconds. The aim is to have 5 sessions of both slow and fast contractions per day. Each session consists of 10 slow and 10 fast contractions.  They will be explained to focus on tightening only pelvic floor muscles and not to flex the muscles in abdomen or thighs. The intervention group subjects will be contacted every week on phone to remind and motivate them about the prescribed intervention. Intervention 2: Control group: The participants in control group will be invited for a group lecture (number could vary) on the earliest possible day at the same center of their enrollment. They will be given a 15 minutes lecture using audio-visual aids on the anatomy of pelvic floor muscles, continence mechanism and importance of doing Kegel exercise to alleviate problems related to UI. The control group participants will not be supervised or reminded by weekly telephone communication.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All collected deidentified IPD from the study titled "Phase II study: The effect of home based Kegel exercise on decreasing severity of symptoms and improving quality of life in Omani females identified to have Stress Urinary Incontinence: A prospective randomized controlled study"

When:
Starting 6 months after publication

To whom:
Academic institutions only

Conditions:
For Systematic Reviews and Metaanalysis

Where to obtain:
Dr. Maisa Al Kiyumi &lt;drmaysa@squ.edu.om&gt;

How to obtain:
Authorized researchers from academic institutions only can get in touch with Dr Maisa Al Kiyumi at her above email address.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maisa Al-Kiyumi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1909, Al-Mawaleh South, Muscat, Oman.</address>
        <city>Muscat</city>
        <country1>Oman</country1>
        <zip>316</zip>
        <telephone>+968 24 143407</telephone>
        <email>maysa8172@gmail.com</email>
        <affiliation>Sultan Qaboos University Hospital</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maisa Hamed Sulaiman Al-Kiyumi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1909, Al-Mawaleh South, Muscat, Oman</address>
        <city>Muscat</city>
        <country1>Oman</country1>
        <zip>316</zip>
        <telephone>+968 24 143407</telephone>
        <email>drmaysa@squ.edu.om</email>
        <affiliation>Sultan Qaboos University Hospital</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Oman</country2>
      <country2>Oman</country2>
      <country2>Oman</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Non-pregnant females.
Able to read and write
Attending the primary healthcare centers for any reason</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Females in the postnatal period (who delivered in the past 6 months).
Women requiring wheel-chair.
Women attending for emergency services.
Women with prolapse grade III and IV according to the classification of International Continence Society (ICS)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N39.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stress Urinary Incontinence</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients in the intervention group will report to the Co-PI who is family physician having undergone special training in Kegel Exercise. She will educate the participants individually using audio-visual aids about the anatomy of pelvic floor muscles, continence mechanism and the importance of Kegel’s exercise in management of UI problems and advice the subjects about daily schedule of performing the Kegel’s exercises. The instructions for Kegel exercise involves endurance and speed training. Endurance training (tonic contractions) of pelvic floor muscles consists of  slow velocity close to maximum contractions for 3-10 seconds (according to the initial pelvic floor assessment) followed by relaxation for similar duration.  For example, if the initial pelvic floor assessment shows a time of sustained contraction of 5 seconds, the woman will be instructed to have slow contractions for 5 seconds for the first week, then increase it to 6 seconds in the next week and so on with the aim of reaching 10 seconds. Thus, the time of sustained contraction will be increased by 1 second per week up to 10 seconds. Speed training (phasic contractions) involves fast moderately strong contractions for 2 seconds followed by relaxation for 2 seconds. The aim is to have 5 sessions of both slow and fast contractions per day. Each session consists of 10 slow and 10 fast contractions.  They will be explained to focus on tightening only pelvic floor muscles and not to flex the muscles in abdomen or thighs. The intervention group subjects will be contacted every week on phone to remind and motivate them about the prescribed intervention.</i_keyword>
      <i_keyword>Control group: The participants in control group will be invited for a group lecture (number could vary) on the earliest possible day at the same center of their enrollment. They will be given a 15 minutes lecture using audio-visual aids on the anatomy of pelvic floor muscles, continence mechanism and importance of doing Kegel exercise to alleviate problems related to UI. The control group participants will not be supervised or reminded by weekly telephone communication.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The frequency of Stress Urinary Incontinence symptoms. Timepoint: At baseline and 12 weeks after intervention. Method of measurement: International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-SF).</prim_outcome>
      <prim_outcome>The severity of Stress Urinary Incontinence symptoms. Timepoint: At baseline and 12 weeks after intervention. Method of measurement: International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-SF).</prim_outcome>
      <prim_outcome>The quality of life of women with Stress Urinary Incontinence. Timepoint: At baseline and 12 weeks after intervention. Method of measurement: International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-SF).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Measure Pelvic Floor Muscle (PFM) strength. Timepoint: At baseline and 12 weeks after intervention. Method of measurement: Vaginal palpation (Oxford Grading System).</sec_outcome>
      <sec_outcome>Measure Pelvic Floor Muscle (PFM) strength and endurance. Timepoint: At baseline and 12 weeks after intervention. Method of measurement: Perineometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sultan Qaboos University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2639-06-19</approval_date>
        <contact_name>Ethics Committee of Ministry of Health</contact_name>
        <contact_address>P.O.Box:393, Post code:100, Muscat, Oman Muscat Muscat Oman</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
